Replimune REPL
NASDAQ REPL
$15.03 -0.26 (-1.67%)
As of: Sep 4, 2026 · 1:40 PM EDT

Replimune (REPL) Interest & Investment Income (2017 - 2026)

Replimune (REPL) posted Interest & Investment Income of $2.4 million for Q1 2026, down 16.76% sequentially from $2.8 million in Q4 2025, and down 59.69% YoY from $5.9 million in Q1 2025.

Analysis

Replimune (REPL) Interest & Investment Income (2017 - 2026) Analysis & Trends

Replimune has reported Interest & Investment Income for 9 years, with the latest figure at $2.4 million in Q1 2026.

  • Quarterly Interest & Investment Income fell 59.69% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (down 35.48% YoY) and the FY2026 annual result came in at $13.6 million, down 35.49% from the prior year.
  • Interest & Investment Income fell to $2.4 million in Q1 2026 per REPL's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $6.2 million in Q2 2023 and troughed at $131000.0 in Q1 2022.
  • A 5-year average of $4.0 million and a median of $4.7 million in 2025 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2023 and 2026: Interest & Investment Income soared 4385.5% in 2023, then plunged 59.69% in 2026.
  • Over 5 years, Interest & Investment Income stood at $2.7 million in 2022, then surged by 112.56% to $5.7 million in 2023, then retreated by 9.66% to $5.1 million in 2024, then slumped by 44.6% to $2.8 million in 2025, then decreased by 16.76% to $2.4 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $2.4 million, $2.8 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 35.58 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 5.13 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 10.98 Mn
10 Replimune 1.46 Bn 1.46 Bn - 1.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.96 Mn
Mar 31, 2026 2.37 Mn
Dec 31, 2025 2.85 Mn
Sep 30, 2025 3.70 Mn
Jun 30, 2025 4.71 Mn
Mar 31, 2025 5.88 Mn
Dec 31, 2024 5.14 Mn
Sep 30, 2024 5.39 Mn
Jun 30, 2024 4.71 Mn
Mar 31, 2024 5.43 Mn
Dec 31, 2023 5.69 Mn
Sep 30, 2023 6.05 Mn
Jun 30, 2023 6.19 Mn
Mar 31, 2023 5.88 Mn
Dec 31, 2022 2.68 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 343,000.00
Mar 31, 2022 131,000.00
Dec 31, 2021 87,000.00
Sep 30, 2021 80,000.00